Biogen Inc (NASDAQ:BIIB)
| 199.45 Delayed Data As of 3:59pm ET |  -0.20 / -0.10%Today’s Change | 187.16 Today|||52-Week Range 468.55 | -16.87% Year-to-Date |
Latest BIIB News | Press Releases
| Krensavage Asset Management, LLC Buys 2, Sells 3 in 1st Quarter May 19 / GuruFocus News - Paid Partner Content | 3 Healthcare Stocks That Are Too Cheap to Ignore May 11 / MotleyFool.com - Paid Partner Content |
| 3 Dividend Stocks That Should Pay You for the Rest of Your Life May 16 / MotleyFool.com - Paid Partner Content | How Are Biotech ETFs Reacting to These Q1 Earnings Releases? May 10 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 199.65 |
| Today’s open | 201.03 |
| Day’s range | 198.77 - 203.87 |
| Volume | 19,141 |
| Average volume (3 months) | 1,274,716 |
| Market cap | $29.2B |
Data as of 3:59pm ET, 05/23/2022
Growth & Valuation
| Earnings growth (last year) | -58.03% |
| Earnings growth (this year) | -19.61% |
| Earnings growth (next 5 years) | -4.00% |
| Revenue growth (last year) | -15.81% |
| P/E ratio | 20.4 |
| Price/Sales | 3.45 |
| Price/Book | 2.69 |
Competitors
Data as of 4:18pm ET, 05/23/2022
Financials
| Next reporting date | July 26, 2022 |
| EPS forecast (this quarter) | $4.09 |
| Annual revenue (last year) | $10.4B |
| Annual profit (last year) | $1.6B |
| Net profit margin | 14.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
